Baidu
map

出血性疾病治疗应用血液制剂的专家共识

2017-07-30 上海市医学会 中国输血杂志.2017,30(7):661-663.

出血性疾病(以下简称出血病)在临床实践中非常常见,应用正确的诊疗措施,对患者的救治非常关键。本分会结合上海的临床用血实际情况,在广泛征求临床一线专家意见的基础上,初步达成本共识。现推荐给与输血相关机构参考或采行。

中文标题:

出血性疾病治疗应用血液制剂的专家共识

发布机构:

上海市医学会

发布日期:

2017-07-30

简要介绍:

出血性疾病(以下简称出血病)在临床实践中非常常见,应用正确的诊疗措施,对患者的救治非常关键。本分会结合上海的临床用血实际情况,在广泛征求临床一线专家意见的基础上,初步达成本共识。现推荐给与输血相关机构参考或采行。

 

拓展指南:血液相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=出血性疾病治疗应用血液制剂的专家共识)] GetToolGuiderByIdResponse(projectId=1, id=e2aa61c0015053ec, title=出血性疾病治疗应用血液制剂的专家共识, enTitle=, guiderFrom=中国输血杂志.2017,30(7):661-663., authorId=null, author=, summary=出血性疾病(以下简称出血病)在临床实践中非常常见,应用正确的诊疗措施,对患者的救治非常关键。本分会结合上海的临床用血实际情况,在广泛征求临床一线专家意见的基础上,初步达成本共识。现推荐给与输血相关机构参考或采行。 , cover=, journalId=null, articlesId=null, associationId=1131, associationName=上海市医学会, associationIntro=null, copyright=0, guiderPublishedTime=Sun Jul 30 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>出血性疾病(以下简称出血病)在临床实践中非常常见,应用正确的诊疗措施,对患者的救治非常关键。本分会结合上海的临床用血实际情况,在广泛征求临床一线专家意见的基础上,初步达成本共识。现推荐给与输血相关机构参考或采行。 </P> <P> </P>拓展指南:<strong>与<font color=red>血液</font>相关指南:</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=e94e71c001a94396" title="2017 KSN临床实践指南:中东呼吸综合征血液透析治疗" target=_blank>2017 KSN临床实践指南:中东呼吸综合征血液透析治疗</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=0081a1c001a9124d" title="血液病/恶性肿瘤患者侵袭性真菌病的诊断标准与治疗原则(第五次修订版)" target=_blank>血液病/恶性肿瘤患者侵袭性真菌病的诊断标准与治疗原则(第五次修订版)</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=9032c1c001a910b0" title="2017 NICE诊断指南:多频生物电阻抗装置指导慢性肾病患者进行血液透析时的液体管理(DG.29)" target=_blank>2017 NICE诊断指南:多频生物电阻抗装置指导慢性肾病患者进行血液透析时的液体管理(DG.29)</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=fcb181c001a904b4" title="2017 国际产妇血液动力学工作组建议:妊娠期动脉功能评估" target=_blank>2017 国际产妇血液动力学工作组建议:妊娠期动脉功能评估</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=35e2c1c001a85ec0" title="未确定侵袭性真菌病的诊断和治疗:血液病/恶性肿瘤患者侵袭性真菌病的诊断标准和治疗原则解读" target=_blank>未确定侵袭性真菌病的诊断和治疗:血液病/恶性肿瘤患者侵袭性真菌病的诊断标准和治疗原则解读</a></li> 更多信息请点击:<a href="//m.capotfarm.com/guideline/list.do?q=%E8%A1%80%E6%B6%B2" target=_blank>有关血液更多指南</a></ul>, tagList=[TagDto(tagId=24403, tagName=出血性疾病), TagDto(tagId=60541, tagName=应用血液制剂)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=11944, appHits=127, showAppHits=0, pcHits=2699, showPcHits=9646, likes=90, shares=8, comments=3, approvalStatus=1, publishedTime=Mon Oct 09 22:00:33 CST 2017, publishedTimeString=2017-07-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Oct 09 22:00:33 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 22:03:23 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=出血性疾病治疗应用血液制剂的专家共识)])
出血性疾病治疗应用血液制剂的专家共识
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2237061, encodeId=9e2b223e0611e, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa8d9536844, createdName=ms6000000954716344, createdTime=Fri Nov 15 10:07:51 CST 2024, time=2024-11-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=895163, encodeId=d3a98951634b, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq14WPQL0yK4t3hWkquEJCTMPLDxicZ1aoSZTN4t46O1o69TkIYdvZdDE3icpcRib6xUZnicW2poUwicwg/132, createdBy=77bd2454786, createdName=ghc695382481, createdTime=Wed Oct 28 20:34:09 CST 2020, time=2020-10-28, status=1, ipAttribution=)]
    2024-11-15 ms6000000954716344 来自湖北省

    有用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2237061, encodeId=9e2b223e0611e, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa8d9536844, createdName=ms6000000954716344, createdTime=Fri Nov 15 10:07:51 CST 2024, time=2024-11-15, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=895163, encodeId=d3a98951634b, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq14WPQL0yK4t3hWkquEJCTMPLDxicZ1aoSZTN4t46O1o69TkIYdvZdDE3icpcRib6xUZnicW2poUwicwg/132, createdBy=77bd2454786, createdName=ghc695382481, createdTime=Wed Oct 28 20:34:09 CST 2020, time=2020-10-28, status=1, ipAttribution=)]
    2020-10-28 ghc695382481

    0

Baidu
map
Baidu
map
Baidu
map